176 related articles for article (PubMed ID: 34667026)
21. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
22. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
[TBL] [Abstract][Full Text] [Related]
23. 'Race' and prostate cancer mortality in equal-access healthcare systems.
Graham-Steed T; Uchio E; Wells CK; Aslan M; Ko J; Concato J
Am J Med; 2013 Dec; 126(12):1084-8. PubMed ID: 24262722
[TBL] [Abstract][Full Text] [Related]
24. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer.
Gaston KE; Kim D; Singh S; Ford OH; Mohler JL
J Urol; 2003 Sep; 170(3):990-3. PubMed ID: 12913756
[TBL] [Abstract][Full Text] [Related]
26. Racial differences in a prostate cancer screening study.
Smith DS; Bullock AD; Catalona WJ; Herschman JD
J Urol; 1996 Oct; 156(4):1366-9. PubMed ID: 8808873
[TBL] [Abstract][Full Text] [Related]
27. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
[TBL] [Abstract][Full Text] [Related]
28. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.
Lowder D; Rizwan K; McColl C; Paparella A; Ittmann M; Mitsiades N; Kaochar S
Cancer Lett; 2022 Apr; 531():71-82. PubMed ID: 35122875
[TBL] [Abstract][Full Text] [Related]
29. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
30. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
31. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
Eastham JA; Carver B; Katz J; Kattan MW
Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
[TBL] [Abstract][Full Text] [Related]
32. Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
Hwang C; Henderson NC; Chu SC; Holland B; Cackowski FC; Pilling A; Jang A; Rothstein S; Labriola M; Park JJ; Ghose A; Bilen MA; Mustafa S; Kilari D; Pierro MJ; Thapa B; Tripathi A; Garje R; Ravindra A; Koshkin VS; Hernandez E; Schweizer MT; Armstrong AJ; McKay RR; Dorff TB; Alva AS; Barata PC
JAMA Netw Open; 2023 Sep; 6(9):e2334208. PubMed ID: 37721753
[TBL] [Abstract][Full Text] [Related]
33. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
[TBL] [Abstract][Full Text] [Related]
34. Racial Disparity in Time Between First Diagnosis and Initial Treatment of Prostate Cancer.
Kinlock BL; Thorpe RJ; Howard DL; Bowie JV; Ross LE; Fakunle DO; LaVeist TA
Cancer Control; 2016 Jan; 23(1):47-51. PubMed ID: 27009456
[TBL] [Abstract][Full Text] [Related]
35. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
36. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Nyame YA; Holt SK; Etzioni RD; Gore JL
Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
[TBL] [Abstract][Full Text] [Related]
37. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418
[TBL] [Abstract][Full Text] [Related]
38. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.
Vidotto T; Imada EL; Faisal F; Murali S; Mendes AA; Kaur H; Zheng S; Xu J; Schaeffer EM; Isaacs WB; Sfanos KS; Marchionni L; Lotan TL
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752203
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
[TBL] [Abstract][Full Text] [Related]
40. Association between exercise and primary incidence of prostate cancer: does race matter?
Singh AA; Jones LW; Antonelli JA; Gerber L; Calloway EE; Shuler KH; Freedland SJ; Grant DJ; Hoyo C; Bañez LL
Cancer; 2013 Apr; 119(7):1338-43. PubMed ID: 23401030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
